SEC Form 4 · accession 0001209191-18-012777
Xencor Inc · XNCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Foster
Officer — Chief Medical Officer
Period of report
Feb 22, 2018
Accepted (ET)
Feb 22, 2018 · 8:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326732
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2018 | M | 10,000 | $0.59 | A | 12,419 | D | |
| Common Stock | Feb 22, 2018 | S | 10,000 | $26.03 | D | 2,419 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $0.59 | Feb 22, 2018 | M | 10,000 | D | — | Sep 25, 2022 | Common Stock | 10,000 | 38,064 | D |
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
- F2The stock option is fully vested.